Evidence map›Paper›PMID 39287016›Full record

ArticleInterdisciplinary cardiovascular and thoracic surgery2024

Totally endoscopic coronary artery bypass grafting: experience in 1500 patients.

Jade Claessens, Loren Packlé, Hanne Oosterbos, Elke Smeets, Jelena Geens, Jens Gielen, Silke Van Genechten, Samuel Heuts, Jos G Maessen, Alaaddin Yilmaz

Abstract read
In one paragraph

Article in Interdisciplinary cardiovascular and thoracic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Observational
  3. Review
  4. Review
  5. Neuroprotective Strategies in Coronary Artery Disease Interventions.Journal of cardiovascular development and disease · 2025
    Review
  6. Totally endoscopic coronary bypass: do we need a robot, a pump or both?Interdisciplinary cardiovascular and thoracic surgery · 2024
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jade ClaessensUHasselt-Hasselt University, Limburg Clinical Research Center, Hasselt, Belgium.ORCID 0000-0001-6303-5938
Loren PackléDepartment of Cardiothoracic Surgery, Jessa Hospital, Hasselt, Belgium.
Hanne OosterbosUHasselt-Hasselt University, Limburg Clinical Research Center, Hasselt, Belgium.
Elke SmeetsUHasselt-Hasselt University, Limburg Clinical Research Center, Hasselt, Belgium.
Jelena GeensUHasselt-Hasselt University, Limburg Clinical Research Center, Hasselt, Belgium.
Jens GielenUHasselt-Hasselt University, Limburg Clinical Research Center, Hasselt, Belgium.
Silke Van GenechtenDepartment of Cardiothoracic Surgery, Jessa Hospital, Hasselt, Belgium.
Samuel HeutsDepartment of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands.ORCID 0000-0003-3531-9997
Jos G MaessenDepartment of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands.ORCID 0000-0003-3230-7712
Alaaddin YilmazDepartment of Cardiothoracic Surgery, Jessa Hospital, Hasselt, Belgium.ORCID 0000-0001-9226-1563

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTotally endoscopic coronary artery bypass grafting (TECAB) is a minimally invasive approach to achieve surgical revascularization through a minimally invasive approach. Still, data regarding non-robotic TECAB are limited. This report presents the results of a TECAB technique using long-shafted instruments, defined as Endo-CABG, from a single-centre experience in 1500 consecutive patients.

methodsOne thousand and five hundred patients underwent Endo-CABG between January 2016 and February 2023. Data were collected retrospectively, and patients were followed up for 1 year. The primary outcome of this study was major adverse cardiac and cerebrovascular events (MACCE)-free survival. Secondary efficacy outcomes were graft failure and mortality. Furthermore, we analysed factors influencing long-term freedom from MACCE and all-cause mortality.

resultsThe mean age was 68 [61-75] years, of which 193 (12.87%) were octogenarians. Multivessel disease was present in 1409 (93.93%) patients, and the mean EuroSCORE II was 1.64 [1.09-2.92] %. All patients underwent full arterial revascularization with bilateral internal mammary grafting in 88.47%. Graft failure occurred in 1.80% of cases after 1 year (n = 27). Thirty-day mortality was 1.73% (n = 26), 1-year survival was 94.7% (95% CI: 93.5-95.9%; n = 26) and 1-year MACCE-free survival was 91.7% (95% CI: 90.2-93.2%). Age, left ventricular ejection fraction, arterial hypertension and urgency were significantly associated with 1-year MACCE-free survival.

conclusionsEndo-CABG appears to be a safe procedure, achieves surgical revascularization and provides good outcomes regarding graft failure and MACCE at 1 year, while age, left ventricular ejection fraction, arterial hypertension and urgency were associated with 1-year outcomes.

Indexed as

Coronary artery diseaseEndoscopic coronary artery bypass grafting

Identifiers

PMID39287016
PMCPMC11434154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.